Form 8-K - Current report:
SEC Accession No. 0001104659-24-030539
Filing Date
2024-03-04
Accepted
2024-03-04 17:22:04
Documents
20
Period of Report
2024-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247711d1_8k.htm   iXBRL 8-K 30456
2 EXHIBIT 1.1 tm247711d1_ex1-1.htm EX-1.1 237204
3 EXHIBIT 5.1 tm247711d1_ex5-1.htm EX-5.1 10403
7 GRAPHIC tm247711d1_ex5-1img01.jpg GRAPHIC 2025
8 GRAPHIC tm247711d1_ex5-1img02.jpg GRAPHIC 2238
9 GRAPHIC tm247711d1_ex5-1img03.jpg GRAPHIC 5574
10 GRAPHIC tm247711d1_ex5-1img04.jpg GRAPHIC 5575
  Complete submission text file 0001104659-24-030539.txt   535645

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atxs-20240304.xsd EX-101.SCH 3018
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20240304_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20240304_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT tm247711d1_8k_htm.xml XML 3616
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 24715893
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)